Hepatic Safety Of Biogen Idec’s Zinbryta Under Close Scrutiny In EU

 
• By Ian Schofield
  
Side effects
The EMA is reviewing the hepatic side-effects of MS drug Zinbryta

More from Drug Safety

More from Pink Sheet